摘要
癌症被认为是世界上发病和死亡的主要原因之一。在过去的四十年中,分子和细胞生物学的突飞猛进已经在癌症研究领域取得了重大突破。然而,抗癌药物的设计和开发证明是一个复杂,昂贵和耗时的过程。为了克服这些限制并管理大量的新兴数据,开发了计算机辅助药物发现/设计(CADD)方法。可以采用计算方法来帮助和设计实验,更重要的是阐明构效关系以推动药物发现和引导优化方法。基于结构和配体的药物设计是CADD中最常用的方法。另外,这两种互补方式所提供的同化效应更加吸引人。如今,实验和计算方法的整合在快速发现新型抗癌疗法方面具有很大的希望。在这篇综述中,我们的目标是通过文献的兴旺模型,对计算机辅助抗肿瘤药物开发的最新技术进行全面的观察。还讨论了与每种传统的计算机模拟方法相关的限制,这可以帮助读者理解用于其分析的最佳计算工具。此外,我们还将介绍抗癌药物开发计算方法的最新进展,并简要介绍结论。
关键词: 癌症,抗癌,药物,基于结构的,基于配体的,整合,药效团,药物重新定位,多药理学。
Current Medicinal Chemistry
Title:Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches
Volume: 24 Issue: 42
关键词: 癌症,抗癌,药物,基于结构的,基于配体的,整合,药效团,药物重新定位,多药理学。
摘要: Cancer is considered as one of the world's leading causes of morbidity and mortality. Over the past four decades, spectacular advances in molecular and cellular biology have led to major breakthroughs in the field of cancer research. However, the design and development of anticancer drugs prove to be an intricate, expensive, and time-consuming process. To overcome these limitations and manage large amounts of emerging data, computer- aided drug discovery/design (CADD) methods have been developed. Computational methods can be employed to help and design experiments, and more importantly, elucidate structure-activity relationships to drive drug discovery and lead optimization methods. Structure- and ligand-based drug designs are the most popular methods utilized in CADD. Additionally, the assimilation provided by these two complementary approaches are even more intriguing. Nowadays, the integration of experimental and computational approaches holds great promise in the rapid discovery of novel anticancer therapeutics. In this review, we aim to provide a comprehensive view on the state-of-the-art technologies for computer-assisted anticancer drug development with thriving models from literature. The limitations associated with each traditional in silico method have also been discussed, which can help the reader to rationale the best computational tool for their analysis. In addition, we will also shed some light on the latest advances in the computational approaches for anticancer drug development and conclude with a brief precis.
Export Options
About this article
Cite this article as:
Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches, Current Medicinal Chemistry 2017; 24 (42) . https://dx.doi.org/10.2174/0929867323666160902160535
DOI https://dx.doi.org/10.2174/0929867323666160902160535 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Developing the Evidence Base for Cancer Chemoprevention: Use of Meta-Analysis
Current Drug Targets Protein Interaction Networks in Metallo Proteins and Docking Approaches of Metallic Compounds with TIMP and MMP in Control of MAPK Pathway
Letters in Drug Design & Discovery Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle
Current Drug Targets Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives
Current Drug Metabolism Bioactive Polyphenols from Healthy Diets and Forest Biomass
Current Nutrition & Food Science An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets
Current Pharmaceutical Design Azathioprine in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Quantitative Imaging Biomarkers and their Emerging Role
Current Medical Imaging NK Cell, Monocyte and Non T Cell Biomarkers as Prognostic Indicators in Cancer Immunotherapy
Current Cancer Therapy Reviews The Role of Oxidative Stress Modulators in Breast Cancer
Current Medicinal Chemistry The Fate of Nanocarriers As Nanomedicines In Vivo: Important Considerations and Biological Barriers to Overcome
Current Medicinal Chemistry The Dark Side of Stem Cells: Triggering Cancer Progression by Cell Fusion
Current Molecular Medicine Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors in Cancer
Current Drug Targets Breakthrough Pain
Current Drug Therapy Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors
Current Medicinal Chemistry 3,4-Dihydropyrimidin-2(1H)-one C5 Amides as Inhibitors of T NFα Production: Synthesis, Biological Evaluation and Molecular Modeling
Letters in Drug Design & Discovery